Cite
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study.
MLA
Ranieri, Girolamo, et al. “Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-Line Therapy in Metastatic Colon Cancer: A Pilot Study.” Frontiers in Oncology, vol. 10, Nov. 2020, p. 590707. EBSCOhost, https://doi.org/10.3389/fonc.2020.590707.
APA
Ranieri, G., Laface, C., Laforgia, M., De Summa, S., Porcelli, M., Macina, F., Ammendola, M., Molinari, P., Lauletta, G., Di Palo, A., Rubini, G., Ferrari, C., & Gadaleta, C. D. (2020). Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study. Frontiers in Oncology, 10, 590707. https://doi.org/10.3389/fonc.2020.590707
Chicago
Ranieri, Girolamo, Carmelo Laface, Mariarita Laforgia, Simona De Summa, Mariangela Porcelli, Francesco Macina, Michele Ammendola, et al. 2020. “Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-Line Therapy in Metastatic Colon Cancer: A Pilot Study.” Frontiers in Oncology 10 (November): 590707. doi:10.3389/fonc.2020.590707.